Replies to post #43375 on Regen BioPharma Inc (RGBP)

[AUGGIE2010]

3. PAYMENTS AND RELATED OBLIGATIONS

3.1. License Fees. In partial consideration for the rights and license granted pursuant to Section 2.1 (Grant of Rights), Licensee shall pay to Licensor:

3.1.1. a non-refundable, upfront payment Fifty Thousand shares of Oncology Pharma, Inc. common stock (50,000 shares of ONPH) as a license initiation fee both of which must be paid no later than April 20, 2021 such payment to be made to Regen Biopharma, Inc.,

[29YEARINVESTOR]

WRONG! THAT IS YOUR ALTERED VERSION!
No one that can read will fall for altered or manipulated false statements!
I provided the link and the truth:

3.1.1. a non-refundable, upfront payment Fifty Thousand shares of Oncology Pharma, Inc. common stock (50,000 shares of ONPH) as a license initiation fee both of which must be paid no later than April 20, 2021 such payment to be made to Regen Biopharma, Inc., a Nevada corporation and the parent of the Licensor.

https://www.otcmarkets.com/filing/html?id=14860710&guid=3hrpUnDRtfTjk3h#EX10_2_HTM